Clinical Trial: Bidirectional Cohort Study on Postoperative Adjuvant Therapy with Transarterial Chemoembolization Combined with Anti-PD-1 Antibody With or Without Donafenib in Hepatocellular Carcinoma Patients at High Risk of Recurrence (China)

China, Oct. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Bidirectional Cohort Study on Postoperative Adjuvant Therapy with Transarterial Chemoembolization Combined with Anti-PD-1 Antibody With or Without Donafenib in Hepatocellular Carcinoma Patients at High Risk of Recurrence'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133654

Registration Time: 2026/09/30

Type: Observational study

Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=340383

Published by HT Digital Content Services with permission from Healt...